Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis.
about
Successful immunotherapy with matrix metalloproteinase-derived peptides in adjuvant arthritis depends on the timing of peptide administrationRegulation of peripheral inflammation by spinal p38 MAP kinase in ratsModulation of T cell function by combination of epitope specific and low dose anticytokine therapy controls autoimmune arthritis.Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1.Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissueInhibition of adjuvant-induced arthritis by nasal administration of novel synthetic peptides from heat shock protein 65.Role of heat shock proteins in protection from and pathogenesis of infectious diseases.Nasal tolerance induction as a potential means of immunotherapy for autoimmune diseases: implications for clinical medicine.Peptide-based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities.Antigen specificity and T-cell clonality in periodontal disease.The gene expression profile of preclinical autoimmune arthritis and its modulation by a tolerogenic disease-protective antigenic challengeTregs and allergic diseaseExogenous tumour necrosis factor alpha induces suppression of autoimmune arthritisSelf heat-shock protein 65-mediated regulation of autoimmune arthritis.The involvement of heat-shock proteins in the pathogenesis of autoimmune arthritis: a critical appraisal.Heat-shock proteins induce T-cell regulation of chronic inflammation.Peptide-based therapeutic vaccines for allergic and autoimmune diseases.Peptide-based immunotherapy: a novel strategy for allergic disease.Heat-shock protein 60 as a tool for novel therapeutic strategies that target the induction of regulatory T cells in human arthritis.Stress, heat shock proteins, and autoimmunity: how immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases.Antigen-specific tolerogenic and immunomodulatory strategies for the treatment of autoimmune arthritis.Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen-specific tolerance.In vivo imaging of the effect of LPS on arterial endothelial cells: molecular imaging of heat shock protein 60 expression.Regulation of autoimmune arthritis by self-heat-shock proteins.Treating arthritis by immunomodulation: is there a role for regulatory T cells?Heat shock proteins are therapeutic targets in autoimmune diseases and other chronic inflammatory conditions.Hsp60 chaperonopathies and chaperonotherapy: targets and agents.Heat shock proteins and their immunomodulatory role in inflammatory arthritis.Combination peptide immunotherapy based on T-cell epitope mapping reduces allergen-specific IgE and eosinophilia in allergic airway inflammation.Immunotherapy with allergen peptides.HSP60: issues and insights on its therapeutic use as an immunoregulatory agentInhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope.Bystander suppression of murine collagen-induced arthritis by long-term nasal administration of a self type II collagen peptide.Heat-shock protein T-cell epitopes trigger a spreading regulatory control in a diversified arthritogenic T-cell response.
P2860
Q24800796-9E58A7A7-BD7C-4C46-BA89-EC61543D01BEQ28469043-BB8C2051-E8AA-42D1-A87A-FCE8416A073CQ33267344-E46F15EC-4A8C-4534-A95D-F2803DC5A3ABQ33665793-6546C64D-119D-40FE-A217-F69F08506BDDQ33769366-6B981F10-D64C-4106-95EB-5D9259747FB1Q33970282-B9CCF8DB-33B2-47B5-A97B-6B4EDC4806F8Q33975393-FC924887-CD6D-4B31-BF8A-3D8E17ECC6F7Q34106906-A329F688-6924-4804-B9D6-4F0E7F56B0D1Q34567730-173860A0-392C-41BF-A467-E2D2B7AAE8E7Q35755287-4DF2B123-1FA4-46ED-9255-2165C4964E3FQ35840722-11AFE610-3558-4031-9E28-765C765C06F6Q35951537-5961CB44-E071-440B-8634-1B6D3A75B51BQ36067286-30134756-2FB6-4F5D-AD71-C8746A3DF7DAQ36076495-DD4145E3-E53C-496D-BD2E-F433C5479D4AQ36079214-4C1F839C-670C-4046-AA5E-C3C485B86385Q36085622-48388D25-1A65-48F5-B37C-A16853D84CF0Q36090197-1A6EECA6-8C9A-405B-9AA0-AD46BFC26007Q36350581-38064605-3D7B-43D3-8AF7-9AC724A487F3Q36480993-ACA3B165-8AA6-4243-B765-D8A452885C41Q36856283-70F1966F-E62C-4B61-B1BA-DB08CD0CCD91Q37051562-91AFAB1E-28ED-48B3-87E4-E86247ABB6C2Q37120690-E7F49BC3-89AA-4FB3-B4C9-3C6054051312Q37171018-95DEEF6A-00CB-4D07-B3DF-DC2E417FC03DQ37235106-5B860D52-3E1C-4505-8E92-9B444CAE288CQ37750140-E4607AA2-A69D-4E1D-A3ED-E7D83F66A000Q38026064-4C5E8DFD-6557-4B04-BA25-F12002551E79Q38167037-41166AA3-7E72-49E1-A040-F0CD4BAC3521Q38895446-66A30AA1-B13A-46AA-A958-01C44F9CEADAQ39527744-C297332A-16C5-406C-B908-9870C062FCB3Q40657944-02F32AD4-9275-48EB-96F3-3B4F6DF08D5EQ42102746-8041F893-69C0-4191-8A51-FA8ECB59F243Q44068971-10388458-CD7A-4321-A3B7-F5C316B65FBEQ47712317-6B28CA05-1324-4D34-A77C-DB6B4B59D2BEQ54119207-208AF054-C56C-4B6C-A08D-168D09301773
P2860
Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Peptide-induced nasal toleranc ...... nduced experimental arthritis.
@ast
Peptide-induced nasal toleranc ...... nduced experimental arthritis.
@en
type
label
Peptide-induced nasal toleranc ...... nduced experimental arthritis.
@ast
Peptide-induced nasal toleranc ...... nduced experimental arthritis.
@en
prefLabel
Peptide-induced nasal toleranc ...... nduced experimental arthritis.
@ast
Peptide-induced nasal toleranc ...... nduced experimental arthritis.
@en
P2093
P2860
P356
P1476
Peptide-induced nasal toleranc ...... nduced experimental arthritis.
@en
P2093
B J Prakken
P J van Kooten
R van der Zee
S M Anderton
W van Eden
P2860
P304
P356
10.1073/PNAS.94.7.3284
P407
P577
1997-04-01T00:00:00Z